Quantcast

Latest chemotherapy Stories

2014-03-03 15:25:51

Researchers from UCLA's Jonsson Comprehensive Cancer Center have developed an innovative cancer-fighting technique in which custom-designed nanoparticles carry chemotherapy drugs directly to tumor cells and release their cargo when triggered by a two-photon laser in the infrared red wavelength. The research findings by UCLA's Jeffrey Zink, a professor of chemistry and biochemistry, and Fuyu Tamanoi, a professor of microbiology, immunology and molecular genetics, and their colleagues were...

2014-03-03 08:31:39

Shortage Could Impact Treatment of Most Chemotherapy Patients WASHINGTON, March 3, 2014 /PRNewswire-USNewswire/ -- The Community Oncology Alliance (COA) has released the results of its IV Fluid Shortage Survey. Sixty-six practices from across the country were surveyed. The results revealed: -- 85% of the practices surveyed have received warnings from multiple manufacturers and/or have been impacted by the shortage of IV fluids -- 44% of the practices surveyed have adjusted...

Better Cancer Treatments May Follow Research In Outer Space
2014-02-28 10:25:13

Rebekah Eliason for redOrbit.com – Your Universe Online Although a necessary evil for a vast amount of people, systemic cancer treatment is an invasive procedure with devastating side effects. People undergoing cancer treatment often experience nausea, immune suppression, hair loss and organ failure. All of this is endured with the hope of exterminating the cancerous tissues in the body. If a treatment were developed to specifically target the cancerous tissue instead of treating the...

2014-02-27 23:27:37

A Belgian research team says new and experimental treatment approaches are poised to extend mesothelioma survival in the future. Raleigh, NC (PRWEB) February 27, 2014 Cancer researchers at Belgium’s Antwerp University Hospital say emerging mesothelioma treatments like hyperthermic intrapleural chemotherapy, immunotherapy, and photodynamic therapy are likely to transform multi-modal treatment of the cancer. As Surviving Mesothelioma reports, the team’s newly- published article in the...

2014-02-27 08:30:00

Patient Recruitment Now Underway at Treatment Centers Across the United States WOODCLIFF LAKE, N.J., Feb. 27, 2014 /PRNewswire/ -- Eisai Inc. today announced the start of a large, randomized Phase 3 trial to compare the efficacy, safety and tolerability of eribulin mesylate to standard weekly paclitaxel as a first- or second- line treatment for HER2-negative locally recurrent or metastatic breast cancer (MBC). Recruitment is currently active for this multicenter study, conducted in...

2014-02-26 08:29:14

Test Offering Through Parkway Cancer Centre Supports Company's Growth in International Markets HACKENSACK, N.J., Feb. 26, 2014 /PRNewswire/ -- Champions Oncology (OTC: CSBR), a company engaged in the development of advanced technology solutions and services to personalize the development and use of oncology drugs, today announced that a leading hospital network in Asia, Parkway Cancer Centre (PCC), will begin offering Champions TumorGrafts(TM) to cancer patients at its three...

2014-02-25 12:27:52

Hyperthermia has shown to greatly improve cancer treatment outcomes when combined with radiation and chemotherapy, but Beverly Hills Thermal Medicine is one of only a few centers to offer it. BEVERLY HILLS, Calif., Feb. 25, 2014 /PRNewswire/ -- /Beverly Hills Thermal Medicine/- Hyperthermia treatments have shown to double response rates of chemotherapy and radiation without side effects, and are an integral part of cancer treatment in Europe, but despite this, it has not gained...

2014-02-22 23:01:25

Careful screening is recommended to protect Non-Hodgkin’s Lymphoma patients against this dangerous side effect of rituximab. Raleigh, NC (PRWEB) February 22, 2014 The Non-Hodgkin’s Lymphoma Center is reporting on a newly-published article illustrating the potential dangers of rituximab therapy. Rituximab is a monoclonal antibody that is often used along with traditional chemotherapy in the treatment of Non-Hodgkin’s Lymphoma and other cancers involving the immune system B-cells....

2014-02-20 12:28:45

PHILADELPHIA, Feb. 20, 2014 /PRNewswire/ -- MS -- According to a new report from the World Health Organization, cancer cases are expected to surge by 20 percent over the next two decades. The World Cancer Report, produced by the WHO's specialized cancer agency, predicts that new cancer cases will rise from 14 million annually in 2012 to 22 million within 20 years, leaving millions more to cope with the disease and the often debilitating and painful side effects of treatment plans that...

2014-02-18 23:24:32

A new study in ovarian cancer patients appears to back up previous research on the value of Vitamin C in the treatment of mesothelioma and other cancers. Raleigh, NC (PRWEB) February 18, 2014 Surviving Mesothelioma is reporting on new research at the University of Kansas that intravenous Vitamin C produces therapeutic levels of the cancer-fighter in the blood, tissue and interstitial fluid (around cells) and kills ovarian cancer cells. The researchers found that Vitamin C damaged the DNA...


Latest chemotherapy Reference Libraries

Intravenous Therapy
2013-04-30 13:16:16

Intravenous therapy, commonly known as IV therapy, is known as the administration of a liquid substance directly into a vein. It is also known as drip therapy, because most often the liquid is suspended above the IV site by an infusion pump, and runs through a drip chamber, which prevents air from entering the line. IVs are the preferred method of drug administration in hospital settings because they are the fastest known route of getting medication to the body. Intravenous therapy can also...

Antiviral Chemistry & Chemotherapy
2012-04-25 09:59:26

Antiviral Chemistry & Chemotherapy is a peer-reviewed academic journal published bi-monthly by International Medical Press in London since 1997. When founded in January 1990, it was published by Blackwell Science. The current editor-in-chief is Hugh J. Field of University of Cambridge, UK. The journal publishes primary papers and reviews on all aspects of the preclinical development of antiviral agents, including their chemical synthesis, biochemistry, pharmacology, mode of action and...

More Articles (2 articles) »
Word of the Day
mundungus
  • A stinking tobacco.
  • Offal; waste animal product; organic matter unfit for consumption.
This word comes from the Spanish 'mondongo,' tripe, entrails.